Agonist actions of dihydroergotamine at 5-HT(2B) and 5-HT(2C) receptors and their possible relevance to antimigraine efficacy

1. The pharmaceutical compound, dihydroergotamine (DHE) is dispensed to prevent and reduce the occurrence of migraine attacks. Although still controversial, the prophylactic effect of this drug is believed to be caused through blockade and/or activation of numerous receptors including serotonin (5-H...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Schaerlinger, B, Hickel, P, Etienne, N, Guesnier, L, Maroteaux, L
Format: Artigo
Jezik:Inglês
Izdano: 2003
Teme:
Papers
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1574033/
https://ncbi.nlm.nih.gov/pubmed/12970106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0705437
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki